Greenstone Voluntary Recalls Citalopram And Finasteride Nationwide Due to Possible Mislabelling
From EquityBites (March 28, 2011)
Greenstone LLC announced on Saturday that it is voluntarily conducting a recall, at the patient level, of medicines with lot number FI0510058-A on the label.
The recall includes Citalopram 10mg Tablets (100-count bottle) and Finasteride 5mg Tablets (90-count bottle), both distributed in the US market.
The recall is reportedly as a result of the possibility that incorrect labels have been placed on the bottles by a third-party manufacturer. This is the only lot number being recalled and no other lots or markets are believed to be impacted, the company said.
More importantly, bottles labelled as Citalopram Lot # FI0510058-A may contain Finasteride. Patients who believe they may have ingested the wrong medication should contact their physician as soon as possible.
Bottles of either Citalopram (used to treat depression) or Finasteride (for the treatment of benign prostatic hyperplasia) with lot number FI050058-A should be returned to the pharmacist.
Greenstone LLC is a wholly owned subsidiary of Pfizer Inc (NYSE:PFE).
((Comments on this story may be sent to firstname.lastname@example.org))
Posted: March 2011